Le Lézard
Classified in: Health
Subjects: NPT, TDS

Ezer Mizion Launches #SharedLife At AIPAC Conference


NEW YORK, March 8, 2018 /PRNewswire/ -- Ezer Mizion, the largest non-profit organization providing health support services in Israel and the largest Jewish bone marrow registry... saving lives globally, launched its new campaign, #SharedLife, at The American Israel Public Affairs Committee (AIPAC) Annual Policy Conference. The campaign showcases the strong connection between a donor and a recipient. Additionally, Ezer Mizion received a recognition for building and maintaining the largest Jewish bone marrow registry.

In 1998, Dr. Bracha and Moti Zisser founded the Ezer Mizion's bone marrow registry. What originally began as a small project has today expanded to be the largest Jewish-specific registry around the world. Through its exclusive partnership, formed in 2005, with the Israel Defense Forces (IDF), Ezer Mizion is able to obtain a fresh pool of pre-screened candidates from each recruitment cycle. To date, its database has 885,264 registrants (including 470,038 IDF recruits), has successfully matched nearly 12,000 patients, and has facilitated nearly 3,000 transplants.

Dr. Bracha Zisser, Director of the Registry, debuted the new campaign and unveiled a donor/recipient duo to demonstrate its impact. Steve Arnow's journey began when he was diagnosed with Myelodysplastic Syndrome. Through Ezer Mizion, he connected with IDF soldier/donor Gev Blau for a transplant. The two were introduced for an emotional first-meeting on the AIPAC stage.

To honor Ezer Mizion, AIPAC shared an emotional video showcasing the organization's impact. Honorable guests were on-site to share in the celebrations. Israeli supermodel Bar Refaeli, a registry member since 2009, has generously lent her support through social media to bring awareness to #SharedLife.

ABOUT EZER MIZION
Established in 1979 by Chananya Chollak, Ezer Mizion is one of the largest non-profit organizations in Israel providing medical support services. The organization's goal is to positively impact the lives of the sick, disabled, elderly, and underprivileged. It benefits 670,000+ people annually, has 25,000+ volunteers, and an annual budget of $100M. One of its key initiatives is the largest Jewish bone marrow registry... saving lives globally, which includes 885,264 active registrants (including 470,038 IDF global recruits). Since its inception, nearly 12,000 positive matches have been established and nearly 3,000 transplants facilitated. To learn more, visit: www.EzerMizion.org.

SOURCE Ezer Mizion


These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: